The shortfall of generic drugs, which comprise the majority of medications that Americans consume, has been a chronic problem, starting well before the mid-2020s.

In terms of the illegal act exclusions, it is vital that plan administrators use their discretionary authority to regularly assess the applicability of these exclusions.